Molecular Profiling of Tisotumab Vedotin–Treated Patients Identifies Immune Pathways Associated with Clinical Activity
- DOI
- 10.1158/1078-0432.ccr-26-0782
- Published
- 2026-08-11
- Container
- Clinical Cancer Research
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/1078-0432.ccr-26-0782,
title = {Molecular Profiling of Tisotumab Vedotin–Treated Patients Identifies Immune Pathways Associated with Clinical Activity},
author = {Sriram Sridhar and M. Guy Roukens and Christina Y. Yu and Tim Dielen and Berris van Kessel-Welmers and Han Si and Steven Xu and Lauren K. Brady and Merzu Belete and Mark Bieda and Khyati N. Shah and Regina Aquino and Denise Gallagher and Craig J. Thalhauser and Brandon W. Higgs and Mark Fereshteh and Maria Jure-Kunkel and Jeffrey R. Harris},
year = {2026},
journal = {Clinical Cancer Research},
doi = {10.1158/1078-0432.ccr-26-0782},
url = {https://doi.org/10.1158/1078-0432.ccr-26-0782}
}RIS
TY - JOUR TI - Molecular Profiling of Tisotumab Vedotin–Treated Patients Identifies Immune Pathways Associated with Clinical Activity AU - Sriram Sridhar AU - M. Guy Roukens AU - Christina Y. Yu AU - Tim Dielen AU - Berris van Kessel-Welmers AU - Han Si AU - Steven Xu AU - Lauren K. Brady AU - Merzu Belete AU - Mark Bieda AU - Khyati N. Shah AU - Regina Aquino AU - Denise Gallagher AU - Craig J. Thalhauser AU - Brandon W. Higgs AU - Mark Fereshteh AU - Maria Jure-Kunkel AU - Jeffrey R. Harris PY - 2026 JO - Clinical Cancer Research DO - 10.1158/1078-0432.ccr-26-0782 UR - https://doi.org/10.1158/1078-0432.ccr-26-0782 ER -
APA
Sridhar, S., Roukens, M. G., Yu, C. Y., Dielen, T., Kessel-Welmers, B. V., Si, H., Xu, S., Brady, L. K., Belete, M., Bieda, M., Shah, K. N., Aquino, R., Gallagher, D., Thalhauser, C. J., Higgs, B. W., Fereshteh, M., Jure-Kunkel, M., & Harris, J. R. (2026). Molecular Profiling of Tisotumab Vedotin–Treated Patients Identifies Immune Pathways Associated with Clinical Activity. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-26-0782
Source records
- crossref · retrieved 2026-09-27T05:07:53.707Z